Perrigo Company plc's latest marketcap:
As of 07/05/2025, Perrigo Company plc's market capitalization has reached $3.74 B. According to our data, Perrigo Company plc is the 4104th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 3.74 B |
Revenue (ttm) | 4.34 B |
Net Income (ttm) | -180,200,000 |
Shares Out | 137.48 M |
EPS (ttm) | -1.31 |
Forward PE | 8.80 |
Ex-Dividend Date | 05/30/2025 |
Earnings Date | 08/01/2025 |
Perrigo Company plc's yearly market capitalization.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
07/05/2025 | $3.74 B | 6.84% | 4104 |
12/31/2024 | $3.51 B | -19.56% | 3896 |
12/29/2023 | $4.36 B | -5% | 3202 |
12/30/2022 | $4.59 B | -11.8% | 2885 |
12/31/2021 | $5.2 B | -14.75% | 3135 |
12/31/2020 | $6.1 B | -13.19% | 2428 |
12/31/2019 | $7.03 B | 33.57% | 1815 |
12/31/2018 | $5.26 B | -57.12% | 1939 |
12/29/2017 | $12.28 B | 2.87% | 1066 |
12/30/2016 | $11.93 B | -43.67% | 862 |
Company Profile
About Perrigo Company plc
Perrigo Company plc is a leading provider of over-the-counter health and wellness solutions, serving customers in the United States, Europe, and internationally. Headquartered in Dublin, Ireland, the company was founded in 1887 and operates through two primary segments: Consumer Self-Care Americas and Consumer Self-Care International.
Product Portfolio
Perrigo offers a diverse range of self-care products, including:
- Upper Respiratory: Cough suppressants, expectorants, and sinus/allergy relief products.
- Nutrition: Infant formulas and nutritional beverages.
- Digestive Health: Antacids, anti-diarrheal, and anti-heartburn solutions.
- Pain & Sleep Aids: Pain relievers and fever reducers.
- Oral Care: Toothbrushes, floss, whitening products, and more.
- Healthy Lifestyle: Smoking cessation and well-being products.
- Skin Care: Dermatological treatments, scar management, and lice solutions.
- Women’s Health: Feminine hygiene and contraceptive products.
- Vitamins & Supplements: Nutritional support for daily wellness.
- Rare Diseases: Specialized treatments for uncommon conditions.
Brand Portfolio
Perrigo's products are sold under well-known brands, including:
- Compeed
- Dr. Fresh
- Mederma
- Prevacid24HR
- Opill
- NiQuitin
- ACO
- ellaOne
Distribution Channels
The company distributes its products through:
- Retail drug, supermarket, and mass merchandise chains.
- E-commerce platforms.
- Wholesalers and pharmacies.
- Drug and grocery retailers.
- Para-pharmacies.
Additionally, Perrigo provides contract manufacturing services to support other brands in the health and wellness space.
Formerly known as Perrigo Company, the firm rebranded as Perrigo Company plc in December 2013.
Frequently Asked Questions
-
What is Perrigo Company plc's (PRGO) current market cap?As of 07/05/2025, Perrigo Company plc (including the parent company, if applicable) has an estimated market capitalization of $3.74 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Perrigo Company plc (PRGO) rank globally by market cap?Perrigo Company plc global market capitalization ranking is approximately 4104 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.